The Class of 2017, the first crop of Generation Z (people born between 1993 and 1999) to enter the workforce, is more interested in working for large companies compared to last year’s grads (19 percent vs. 14 percent), according to a new study by Accenture Strategy on the future workforce. New graduates desire an engaging employee experience and want to take full advantage of their degree. The fifth annual Accenture Strategy 2017 U.S. College Graduate Employment Study also found that this generation is more prepared to enter the workforce and desires in-person interaction.
To view the multimedia release go to:
https://www.multivu.com/players/English/8076751-accenture-generation-z-workforce-study/
For countless fans, Cholula®, the hot sauce with the iconic wooden cap, is far more than “just another hot sauce.” It’s an ongoing inspiration and constant companion to their personal passions. This cult-like devotion has been integral to Cholula’s rapid growth and with the help of All-Star pitcher Noah Syndergaard, the brand is thanking fans for their support by launching the “Order of Cholula,” a digital homage to its most loyal supporters and releasing a new Limited Edition flavor, Sweet Habanero.
The first person to join the Order of Cholula is Noah Syndergaard. Known for his on-field prowess and flavorful character, Noah shares his love for Cholula by headlining a recruitment-style video debuting today at www.OrderofCholula.com. The captivating short film features inspiring stories of real Cholula fans who credit the role the flavorful hot sauce plays in their lives – including Syndergaard himself. The video encourages viewers to join Noah and other flavor-seeking zealots by applying for admittance into this members-only club by sharing their Order-worthy stories of Cholula devotion.
To view the multimedia release go to:
https://www.multivu.com/players/English/8118351-order-of-cholula-noah-syndergaard-sweet-habanero/
NEW YORK, NY (January 28, 2019) – Today, CancerCare celebrated its 75th anniversary by revealing a new campaign “If It Matters To You, It Matters To Us.” The campaign declares CancerCare’s commitment to holistic, patient-centered support services, and celebrates a legacy of comprehensive care for people living with cancer.
“A cancer diagnosis turns a person’s life upside down. Throughout many doctors’ visits, tests and treatments, people with cancer often feel like they’re perceived as a patient rather than a person,” said CancerCare CEO, Patricia Goldsmith. “For 75 years, CancerCare has championed the importance of addressing what matters most to patients and their families through free, direct services to help cope with the emotional, practical and financial challenges of a cancer diagnosis.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8350251-cancercare-75th-anniversary-cancer-community/
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
Imagine finding the most qualified candidate for a job, but that person is blind. Or perhaps a long-term employee experiences vision loss as a result of an accident. What would an employer need to do to accommodate that person? Is the employee able to keep the job?
Serving as a national model for how technology can create job opportunities and accessible workplaces for people without vision, Indianapolis-based nonprofit Bosma Enterprises is one of the first organizations in the U.S. to use BlindSquare, an innovative wayfinding technology. Bosma is using BlindSquare to help clients and employees better navigate its new, state-of-the-art headquarters, which opened June 2, and is representative of the nonprofit’s mission to assist people who are blind or visually impaired gain the life skills they need to remain independent, and the job skills they need to stay self-sufficient.
To view the multimedia release go to:
https://www.multivu.com/players/English/8116051-bosma-enterprises-blindsquare-mobile-navigation-technology/
An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal disease and its potential consequences. Almost 7 in 10 parents said they don’t know enough about the different strains of meningococcal disease and the potential damage they can cause. On average, more than half of parents were either unsure or unaware that there are different types of bacteria that cause the disease.
The survey of 5,000 parents in Brazil, Canada, Germany, Italy and Portugal also shows that out of a list of 14 vaccine-preventable diseases, meningococcal disease is considered by many parents to pose a top three health risk to their children. Fifty-seven percent listed meningococcal disease among the top three health conditions they considered of greatest risk to children followed by Hepatitis B at 34 percent, pneumococcal disease at 27 percent, polio at 25 percent, tetanus at 20 percent and pertussis at 17 percent.
A sudden, potentially life-threatening illness, meningococcal disease kills on average one person every eight minutes worldwide. It typically manifests as bacterial meningitis – an infection of the membrane around the brain and spine; or bacteraemia – a bloodstream infection. The disease progresses rapidly and it can lead to death within 24-48 hours of the first symptoms; globally up to 1 in 10 of those infected may die and in the US about 10-15 percent of people will die.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7814851-gsk-survey-world-meningitis-day/
The holiday season provides the perfect opportunity to give thanks and to give back to youth who are facing challenges within our communities. In days of uncertainty, there are still people who are providing direction and mentoring to high-risk youth to help them succeed in spite of the unfortunate circumstances they may have encountered. Many studies indicate that a young person’s success can be greatly enhanced by an advocate or mentor — an adult who consistently helps a young person stay on track to graduate and make better life choices. Goodwill’s GoodGuides program is the source of many modern-day mentoring success stories.
The GoodGuides program provides mentoring to youth, ages 12–17, who are at risk of dropping out of school and/or falling into delinquency. The program helps them finish school, transition into the world of work and prepare for success by pairing them with trusted adult volunteer mentors. Mentors help youth overcome disadvantages such as failure in school due to poor grades or low attendance, or avoid delinquency due to issues such as abuse, disability, drug or alcohol dependence, family violence or gang membership.
To view the multimedia release go to:
http://www.multivu.com/players/English/7057252-goodwill-givegoodwill-campaign/
Check out our site at http://www.BengawanSEO.com Are
you a type of person who like playing game with bored faced.. while
waiting sales on your online store. Playing... Playing... till
...lay...iiing and suddenly wake up receiving notification email
updates yet false alarm. you ignore it and continue playing.. playing..
laying down soon laying down for good and forget your purpose of
waiting. :)How troublesome if you waiting for online sales but
your site still at unknown pages and ranks. Introduce us Bengawan SEO,
a SEO services provider and also a professional SEO company that can
help you reach better visibility towards your potential visitor.Let's
gain visibility, sales and ROI with Us.
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
http://circustime.net/sports-mania/quaterback-blitz.html Set!
Down! Hike! Test your throwing accuracy against a friend. When you
throw a football through one of the targets the ball transfers into
your opponent's lane. The person who has the least amount of balls in
their lane at the end of the time is the winner.
We Don't Choose Our Parents,Siblings,And Realtives. However, We Choose Our Spouse, We Chose The Person Who Will Have The Most Impact In Our Life. A General Talk By Daee Ahmed Moait. Learn From The Experience Of Others.
The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
